SMMT

Summit Therapeutics
D

SMMT

15.110
USD
-1.09
(-6.73%)
مغلق
حجم التداول
70,347
الربح لكل سهم
-1
العائد الربحي
-
P/E
-12
حجم السوق
11,723,635,224
أصول ذات صلة المقالات

العنوان: Summit Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.